dasatinib

Generic: dasatinib

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name dasatinib
Generic Name dasatinib
Labeler bluepoint laboratories
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

dasatinib 50 mg/1

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-661
Product ID 68001-661_3ff0e7fd-3f99-fbdd-e063-6294a90a24c7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217217
Listing Expiration 2026-12-31
Marketing Start 2025-09-29

Pharmacologic Class

Classes
cytochrome p450 3a4 inhibitors [moa] kinase inhibitor [epc] protein kinase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001661
Hyphenated Format 68001-661

Supplemental Identifiers

RxCUI
643105 643107 643109 799047 1045402 1045406
UPC
0368001662062 0368001661065 0368001665049 0368001663045 0368001664042
UNII
RBZ1571X5H

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dasatinib (source: ndc)
Generic Name dasatinib (source: ndc)
Application Number ANDA217217 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 60 TABLET, FILM COATED in 1 BOTTLE (68001-661-06)
source: ndc

Packages (1)

68001-661-06 60 TABLET, FILM COATED in 1 BOTTLE (68001-661-06)

Ingredients (1)

dasatinib (50 mg/1)

Linked Drug Pages (1)

Dasatinib ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3ff0e7fd-3f99-fbdd-e063-6294a90a24c7", "openfda": {"upc": ["0368001662062", "0368001661065", "0368001665049", "0368001663045", "0368001664042"], "unii": ["RBZ1571X5H"], "rxcui": ["643105", "643107", "643109", "799047", "1045402", "1045406"], "spl_set_id": ["02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (68001-661-06)", "package_ndc": "68001-661-06", "marketing_start_date": "20250929"}], "brand_name": "Dasatinib", "product_id": "68001-661_3ff0e7fd-3f99-fbdd-e063-6294a90a24c7", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "68001-661", "generic_name": "dasatinib", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dasatinib", "active_ingredients": [{"name": "DASATINIB", "strength": "50 mg/1"}], "application_number": "ANDA217217", "marketing_category": "ANDA", "marketing_start_date": "20250929", "listing_expiration_date": "20261231"}